L-Carnitine is an amino acid derivative that is best known for its role in the fatty acid oxidation — it is the essential cofactor for the transport of the long-chain fatty acids into the mitochondrial matrix for beta-oxidation, and it is therefore essential for the generation of the ATP from the fat in the heart, the skeletal muscle, and the liver. However, L-carnitine also plays a critically important role in male fertility — it is present in very high concentrations in the epididymis and in the seminal plasma (approximately 100-200 times higher than in the blood), and it is the primary energy source for the maturing sperm cells as they traverse the epididymis and as they acquire the motility that is essential for the fertilisation. The maturing sperm cells rely entirely on the fatty acid oxidation for their energy needs (because they have no glycogen stores and because they derive their ATP primarily from the mitochondrial beta-oxidation of the fatty acids that are available in the epididymal fluid). Without adequate L-carnitine, the sperm cells cannot generate sufficient ATP from the fatty acid oxidation, their motility is impaired, and the asthenozoospermia (reduced sperm motility) and the oligozoospermia (reduced sperm count) develop — these are the primary manifestations of the carnitine deficiency in men and the primary causes of the male infertility that is associated with the low carnitine levels.
Carnitine and the Sperm Energy Metabolism
The sperm cells undergo a complex maturation process as they traverse the epididymis — they acquire the progressive motility, they develop the surface antigens that are required for the recognition of the oocyte, and they undergo the capacitation (the final maturation step that occurs in the female reproductive tract and that enables them to fertilise the oocyte). This maturation process is entirely dependent on the ATP supply from the mitochondrial beta-oxidation, and it is therefore critically dependent on the availability of the L-carnitine in the epididymal fluid. The L-carnitine in the epididymis is derived from the blood (where it is transported by the organic cation/carnitine transporter, OCTN2) and from the de novo synthesis in the epididymal epithelial cells. The concentration of L-carnitine in the epididymis is approximately 0.5-1.5mM — which is approximately 100-200 times higher than in the blood — and this high concentration is maintained by the active transport of L-carnitine from the blood into the epididymal epithelial cells and from the epididymal epithelial cells into the epididymal fluid.
The clinical importance of the L-carnitine for the sperm motility is underscored by the observation that the carnitine supplementation improves the sperm motility and the sperm count in men with the asthenozoospermia and with the oligozoospermia. Multiple RCTs and meta-analyses have demonstrated that L-carnitine supplementation at 2-3g daily (for 3-6 months) significantly improves the sperm motility (by 15-30%), the sperm count (by 10-20%), and the pregnancy rate (by 5-10%) in men with the male factor infertility. The proposed mechanism of this benefit involves the restoration of the normal fatty acid oxidation and the ATP production in the maturing sperm cells, which enables them to develop the progressive motility that is essential for the fertilisation.
Carnitine and the Oxidative Stress in Sperm
Beyond its role as an energy substrate for the sperm cells, L-carnitine also has antioxidant effects in the male reproductive tract — it reduces the oxidative stress in the semen, which is one of the most important causes of the sperm DNA damage and of the male factor infertility. The mechanism of this antioxidant effect involves the reduction of the reactive oxygen species (ROS) production by the sperm mitochondria (by improving the efficiency of the fatty acid oxidation and thereby reducing the electron leakage and the ROS formation), the direct neutralisation of the ROS by the L-carnitine molecule (which has a free thiol group that can donate electrons to the ROS), and the support of the glutathione peroxidase activity (by maintaining the reduced glutathione pool in the sperm cells). The reduction of the oxidative stress in the semen is one of the most important mechanisms of the carnitine-induced improvement in the sperm function and in the fertilisation success.
Practical Application
For general L-carnitine supplementation for male fertility, the evidence-based approach is to supplement with 2-3g of L-carnitine daily (as the L-carnitine L-tartrate or as the acetyl-L-carnitine form, which is better absorbed and more bioavailable for the reproductive tissues). The supplementation should be continued for at least 3-6 months (the time required for the full spermatogenesis cycle) before assessing the efficacy. For comprehensive male fertility support, L-carnitine pairs well with the coenzyme Q10 (which is required for the electron transport chain in the sperm mitochondria and which has been shown to improve the sperm motility and the sperm count), with the zinc (which is required for the sperm motility and for the testosterone synthesis), with the folate (which is required for the DNA synthesis in the rapidly dividing spermatogonia), and with the vitamin E (which has antioxidant effects in the semen and which protects the sperm DNA from the oxidative damage).
Leave a Reply